Companies Dominating the Controlled Substance API Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson
- Novartis AG
- Roche Holding AG
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline plc
- Eli Lilly and Company
- AstraZeneca plc
- Merck & Co., Inc.
- AbbVie Inc.
Browse Key Market Insights with Data Illustration:
In the News
- Novartis to lay off 8,000 jobs worldwide. The Swiss pharmaceutical company announced plans to cut 8,000 jobs, or 7% of its workforce, in a bid to save USD 1 billion. The layoffs will affect employees across all levels and functions, and will be implemented over the next two years.
- Novartis receives positive CHMP opinion for multiple sclerosis biosimilar natalizumab. The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Novartis's biosimilar natalizumab, which is used to treat multiple sclerosis.
